Ghép tế bào huyết học đồng loại sau khi điều trị bằng kháng thể 131I–anti-CD45 kết hợp với fludarabine và chiếu xạ toàn thân liều thấp cho bệnh nhân cao tuổi mắc bệnh bạch cầu myeloid cấp tiến triển hoặc hội chứng myelodysplastic nguy cơ cao

Giralt, 1997, Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy., Blood, 89, 4531, 10.1182/blood.V89.12.4531 Slavin, 1998, Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases., Blood, 91, 756, 10.1182/blood.V91.3.756 Storb, 1997, Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation., Blood, 89, 3048, 10.1182/blood.V89.8.3048 McSweeney, 2001, Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects., Blood, 97, 3390, 10.1182/blood.V97.11.3390 Sandmaier, 2004, Nonmyeloablative therapy and hematopoietic cell transplantation for hematologic disorders., Thomas' Hematopoietic Cell Transplantation, 3rd ed., 1164 Maris, 2003, HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies., Blood, 102, 2021, 10.1182/blood-2003-02-0482 Niederwieser, 2003, Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases., Blood, 101, 1620, 10.1182/blood-2002-05-1340 Rezvani, 2008, Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma., J Clin Oncol, 26, 211, 10.1200/JCO.2007.11.5477 Burroughs, 2008, Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma., Biol Blood Marrow Transplant, 14, 1279, 10.1016/j.bbmt.2008.08.014 Hegenbart, 2006, Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors., J Clin Oncol, 24, 444, 10.1200/JCO.2005.03.1765 Gyurkocza, 2008, Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with de novo and secondary acute myeloid leukemia [abstract]., Blood, 112, 10.1182/blood.V112.11.149.149 Laport, 2008, Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders., Biol Blood Marrow Transplant, 14, 246, 10.1016/j.bbmt.2007.11.012 Kahl, 2007, Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning., Blood, 110, 2744, 10.1182/blood-2007-03-078592 Matthews, 1999, Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome., Blood, 94, 1237, 10.1182/blood.V94.4.1237 Pagel, 2006, Targeted radiotherapy using 131I-anti-CD45 antibody followed by allogeneic hematopoietic cell transplantation (HCT): the relationships among dosimetry, bone marrow uptake, and relapse., Eur J Nucl Med Mol Imaging, 33, S193 Pagel, 2006, 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission., Blood, 107, 2184, 10.1182/blood-2005-06-2317 Scheinberg, 1991, A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide., J Clin Oncol, 9, 478, 10.1200/JCO.1991.9.3.478 Appelbaum, 1992, The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia., Transplantation, 54, 829, 10.1097/00007890-199211000-00012 Waldmann, 1992, The multichain interleukin-2 receptor: a target for immunotherapy., Ann Intern Med, 116, 148, 10.7326/0003-4819-116-2-148 Kaminski, 1993, Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody., N Engl J Med, 329, 459, 10.1056/NEJM199308123290703 Press, 1993, Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support., N Engl J Med, 329, 1219, 10.1056/NEJM199310213291702 Schwartz, 1993, Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemias., J Clin Oncol, 11, 294, 10.1200/JCO.1993.11.2.294 Press, 1995, Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas., Lancet, 346, 336, 10.1016/S0140-6736(95)92225-3 Waldmann, 1995, Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac., Blood, 86, 4063, 10.1182/blood.V86.11.4063.bloodjournal86114063 Petersdorf, 2004, Limits of HLA mismatching in unrelated hematopoietic cell transplantation., Blood, 104, 2976, 10.1182/blood-2004-04-1674 Eary, 1990, Imaging and treatment of B-cell lymphoma., J Nucl Med, 31, 1257 Cancer Therapy Evaluation Program (National Cancer Institute) common toxicity criteria, version 2.0. Accessed March 1, 2009 http://ctep.info.nih.gov Sgouros, 1993, Bone marrow dosimetry for radioimmunotherapy: theoretical considerations., J Nucl Med, 34, 689 Siegel, 1990, Bone marrow dosimetry and toxicity for radioimmunotherapy., Antibody Immunoconj Radiopharm, 3, 213 Fisher, 1991, Internal radiation dosimetry for clinical testing of radiolabeled monoclonal antibodies., Antibody Immunoconj Radiopharm, 4, 655 Siegel, 1990, Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody., Cancer Res, 50, 1039s Bearman, 1988, Regimen-related toxicity in patients undergoing bone marrow transplantation., J Clin Oncol, 6, 1562, 10.1200/JCO.1988.6.10.1562 Storer, 1993, Small-sample confidence sets for the MTD in a phase I clinical trial., Biometrics, 49, 1117, 10.2307/2532253 Kaplan, 1958, Nonparametric estimation from incomplete observations., J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Gooley, 1999, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators., Statist Med, 18, 695, 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O Slovak, 2000, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study., Blood, 96, 4075, 10.1182/blood.V96.13.4075 Przepiorka, 1995, 1994 Consensus Conference on Acute GVHD Grading., Bone Marrow Transplant, 15, 825 Martin, 2004, Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation., Biol Blood Marrow Transplant, 10, 320, 10.1016/j.bbmt.2003.12.304 Sierra, 1997, Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose., Blood, 89, 4226, 10.1182/blood.V89.11.4226 Miller, 1991, Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation., Blood, 78, 1125, 10.1182/blood.V78.4.1125.1125 Clift, 1990, Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens., Blood, 76, 1867, 10.1182/blood.V76.9.1867.1867 Clift, 1991, Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens., Blood, 77, 1660, 10.1182/blood.V77.8.1660.1660 Matthews, 1992, Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody., Cancer Res, 52, 1228 Matthews, 1991, Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque., Blood, 78, 1864, 10.1182/blood.V78.7.1864.1864 Rosario, 2001, Radiolabeled anti-CD45 with cyclophosphamide (CY) and total body irradiation (TBI) followed by allogeneic hematopoietic stem cell transplantation (HSCT) for patients with advanced acute myeloid leukemia (AML) or myelodysplastic syndrome [abstract]., Blood, 98, 857a Hogan, 2004, Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients., Blood, 103, 78, 10.1182/blood-2003-04-1311 Mielcarek, 2005, Prognostic relevance of ‘early-onset’ graft-versus-host disease following non-myeloablative haematopoietic cell transplantation., Br J Haematol, 129, 381, 10.1111/j.1365-2141.2005.05458.x Wong, 2003, Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years., Blood, 102, 3052, 10.1182/blood-2003-03-0855 Kroger, 2003, Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia., Ann Hematol, 82, 336, 10.1007/s00277-003-0654-9 Sorror, 2008, Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning., J Clin Oncol, 26, 4912, 10.1200/JCO.2007.15.4757 Pagel, 2008, Radioimmunotherapeutic approaches for leukemia: the past, present and future., Cytotherapy, 10, 13, 10.1080/14653240701679881 van der Jagt, 1992, Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model., Cancer Res, 52, 89 Omary, 1980, Human homologue of murine T200 glycoprotein., J Exp Med, 152, 842, 10.1084/jem.152.4.842 Taetle, 1991, Regulation of CD45 expression in human leukemia cells., Leukemia, 5, 309 Glatting, 2006, Anti-CD45 monoclonal antibody YAML568: a promising radioimmunoconjugate for targeted therapy of acute leukemia., J Nucl Med, 47, 1335 Jurcic, 2000, Antibody therapy of acute myelogenous leukemia., Cancer Biother Radiopharm, 15, 319, 10.1089/cbr.2000.15.319 Jurcic, 2000, Potential for myeloablation with yttrium-90-HuM195 (anti-CD33) in myeloid leukemia [abstract]., J Clin Oncol, 19, 8a